The V Foundation seeks to support translational research projects within the scope of all types of cancers.
Projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposals. The endpoint of the project should be the planning or initiation of a new clinical trial.
The Cancer Center may nominate up to two nominees for the 2017 Cancer Research Grant Program Translational Award, if at least one of the two nominee applicants is submitting a research project that focuses on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in cancer causes, aggressiveness, treatment or relapse. Minorities for the purposes of the application are defined as African Americans or people of African descent, Pacific Islanders, Hispanic Americans, and Native Americans and Alaskan Natives.
Special Focus area: Any area of cancer research is permitted. Research on cancers that are more prevalent or aggressive in specific ethnic populations is encouraged, but not required. Cancers in which ethnic and racial disparities have previously been shown include: lung and bronchus, colon and rectum, breast prostate, uterine, cervix, stomach and liver.